Advertisement

Index by Author

September 1996; 45 (9)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Andersson, A

    • Efficient gene transfer to dispersed human pancreatic islet cells in vitro using adenovirus-polylysine/DNA complexes or polycationic liposomes. Diabetes September 1996 45:1197-1203; doi:10.2337/diabetes.45.9.1197

  2. Armstrong, D

    • Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants. Diabetes September 1996 45:1233-1237; doi:10.2337/diabetes.45.9.1233

  3. Asano, T

    • Effect of mitochondrial and/or cytosolic glycerol 3-phosphate dehydrogenase overexpression on glucose-stimulated insulin secretion from MIN6 and HIT cells. Diabetes September 1996 45:1238-1244; doi:10.2337/diabetes.45.9.1238

B

  1. Barrera-Hernandez, G

    • Phlorizin or vanadate treatment reverses impaired expression of albumin and hepatocyte nuclear factor 1 in diabetic rats. Diabetes September 1996 45:1217-1222; doi:10.2337/diabetes.45.9.1217

  2. Beattie, G M

    • Regulation of proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, hepatocyte growth factor, and cell-cell contact. Diabetes September 1996 45:1223-1228; doi:10.2337/diabetes.45.9.1223

  3. Bergerot, I

    • Lymphocyte function associated antigen-1, integrin alpha 4, and L-selectin mediate T-cell homing to the pancreas in the model of adoptive transfer of diabetes in NOD mice. Diabetes September 1996 45:1181-1186; doi:10.2337/diabetes.45.9.1181

  4. Biessels, G J

    • Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes September 1996 45:1259-1266; doi:10.2337/diabetes.45.9.1259

  5. Bogardus, C

    • Absence of linkage of obesity and energy metabolism to markers flanking homologues of rodent obesity genes in Pima Indians. Diabetes September 1996 45:1229-1232; doi:10.2337/diabetes.45.9.1229

  6. Bolli, G B

    • Contribution of amino acids and insulin to protein anabolism during meal absorption. Diabetes September 1996 45:1245-1252; doi:10.2337/diabetes.45.9.1245

  7. Bonner-Weir, S

    • Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes September 1996 45:1161-1167; doi:10.2337/diabetes.45.9.1161

  8. Brunetti, P

    • Contribution of amino acids and insulin to protein anabolism during meal absorption. Diabetes September 1996 45:1245-1252; doi:10.2337/diabetes.45.9.1245

  9. Buschard, K

    • Efficient gene transfer to dispersed human pancreatic islet cells in vitro using adenovirus-polylysine/DNA complexes or polycationic liposomes. Diabetes September 1996 45:1197-1203; doi:10.2337/diabetes.45.9.1197

C

  1. Caro, J F

    • Effect of troglitazone on leptin production. Studies in vitro and in human subjects. Diabetes September 1996 45:1276-1278; doi:10.2337/diabetes.45.9.1276

  2. Christiansen, E

    • Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover. Diabetes September 1996 45:1267-1275; doi:10.2337/diabetes.45.9.1267

  3. Christie, M R

    • Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes September 1996 45:1187-1192; doi:10.2337/diabetes.45.9.1187

  4. Chua, S C, Jr

    • Absence of linkage of obesity and energy metabolism to markers flanking homologues of rodent obesity genes in Pima Indians. Diabetes September 1996 45:1229-1232; doi:10.2337/diabetes.45.9.1229

  5. Chung, W K

    • Absence of linkage of obesity and energy metabolism to markers flanking homologues of rodent obesity genes in Pima Indians. Diabetes September 1996 45:1229-1232; doi:10.2337/diabetes.45.9.1229

  6. Cohen, I R

    • The hsp60 peptide p277 arrests the autoimmune diabetes induced by the toxin streptozotocin. Diabetes September 1996 45:1168-1172; doi:10.2337/diabetes.45.9.1168

  7. Considine, R V

    • Effect of troglitazone on leptin production. Studies in vitro and in human subjects. Diabetes September 1996 45:1276-1278; doi:10.2337/diabetes.45.9.1276

  8. Cruciani, G

    • Contribution of amino acids and insulin to protein anabolism during meal absorption. Diabetes September 1996 45:1245-1252; doi:10.2337/diabetes.45.9.1245

  9. Curiel, D T

    • Efficient gene transfer to dispersed human pancreatic islet cells in vitro using adenovirus-polylysine/DNA complexes or polycationic liposomes. Diabetes September 1996 45:1197-1203; doi:10.2337/diabetes.45.9.1197

D

  1. D'Erme, M

    • Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes. Diabetes September 1996 45:1193-1196; doi:10.2337/diabetes.45.9.1193

  2. Davalli, A M

    • Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes September 1996 45:1161-1167; doi:10.2337/diabetes.45.9.1161

  3. De Feo, P

    • Contribution of amino acids and insulin to protein anabolism during meal absorption. Diabetes September 1996 45:1245-1252; doi:10.2337/diabetes.45.9.1245

  4. Di Mario, U

    • Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes. Diabetes September 1996 45:1193-1196; doi:10.2337/diabetes.45.9.1193

  5. Dionisi, S

    • Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes. Diabetes September 1996 45:1193-1196; doi:10.2337/diabetes.45.9.1193

  6. Doherty, C C

    • A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes September 1996 45:1204-1208; doi:10.2337/diabetes.45.9.1204

  7. Dotta, F

    • Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes. Diabetes September 1996 45:1193-1196; doi:10.2337/diabetes.45.9.1193

  8. Doukas, J

    • Anti-endothelial cell autoantibodies in BB rats with spontaneous and induced IDDM. Diabetes September 1996 45:1209-1216; doi:10.2337/diabetes.45.9.1209

E

  1. Eisenbarth, G S

    • Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes. Diabetes September 1996 45:1193-1196; doi:10.2337/diabetes.45.9.1193

  2. Eizirik, D L

    • Efficient gene transfer to dispersed human pancreatic islet cells in vitro using adenovirus-polylysine/DNA complexes or polycationic liposomes. Diabetes September 1996 45:1197-1203; doi:10.2337/diabetes.45.9.1197

  3. Elias, D

    • The hsp60 peptide p277 arrests the autoimmune diabetes induced by the toxin streptozotocin. Diabetes September 1996 45:1168-1172; doi:10.2337/diabetes.45.9.1168

  4. Engerman, R L

    • Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants. Diabetes September 1996 45:1233-1237; doi:10.2337/diabetes.45.9.1233

  5. Erkelens, D W

    • Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes September 1996 45:1259-1266; doi:10.2337/diabetes.45.9.1259

F

  1. Fabien, N

    • Lymphocyte function associated antigen-1, integrin alpha 4, and L-selectin mediate T-cell homing to the pancreas in the model of adoptive transfer of diabetes in NOD mice. Diabetes September 1996 45:1181-1186; doi:10.2337/diabetes.45.9.1181

  2. Fogarty, D G

    • A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes September 1996 45:1204-1208; doi:10.2337/diabetes.45.9.1204

G

  1. Gianani, R

    • Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes. Diabetes September 1996 45:1193-1196; doi:10.2337/diabetes.45.9.1193

  2. Gispen, W H

    • Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes September 1996 45:1259-1266; doi:10.2337/diabetes.45.9.1259

H

  1. Hanabusa, T

    • Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes September 1996 45:1279-1281; doi:10.2337/diabetes.45.9.1279

  2. Hänninen, A

    • Mucosa-associated (beta 7-integrinhigh) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior. Diabetes September 1996 45:1173-1180; doi:10.2337/diabetes.45.9.1173

  3. Harron, J C

    • A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes September 1996 45:1204-1208; doi:10.2337/diabetes.45.9.1204

  4. Hawkes, C J

    • Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes September 1996 45:1187-1192; doi:10.2337/diabetes.45.9.1187

  5. Hayek, A

    • Regulation of proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, hepatocyte growth factor, and cell-cell contact. Diabetes September 1996 45:1223-1228; doi:10.2337/diabetes.45.9.1223

  6. Hollister, J

    • Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes September 1996 45:1161-1167; doi:10.2337/diabetes.45.9.1161

  7. Holst, J J

    • Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover. Diabetes September 1996 45:1267-1275; doi:10.2337/diabetes.45.9.1267

  8. Hother-Nielsen, O

    • Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover. Diabetes September 1996 45:1267-1275; doi:10.2337/diabetes.45.9.1267

  9. Hughes, A E

    • A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes September 1996 45:1204-1208; doi:10.2337/diabetes.45.9.1204

  10. Hutton, J C

    • Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes September 1996 45:1187-1192; doi:10.2337/diabetes.45.9.1187

I

  1. Inukai, K

    • Effect of mitochondrial and/or cytosolic glycerol 3-phosphate dehydrogenase overexpression on glucose-stimulated insulin secretion from MIN6 and HIT cells. Diabetes September 1996 45:1238-1244; doi:10.2337/diabetes.45.9.1238

  2. Ishihara, H

    • Effect of mitochondrial and/or cytosolic glycerol 3-phosphate dehydrogenase overexpression on glucose-stimulated insulin secretion from MIN6 and HIT cells. Diabetes September 1996 45:1238-1244; doi:10.2337/diabetes.45.9.1238

J

  1. Jalkanen, S

    • Mucosa-associated (beta 7-integrinhigh) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior. Diabetes September 1996 45:1173-1180; doi:10.2337/diabetes.45.9.1173

  2. Jensen-Urstad, K J

    • Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes September 1996 45:1253-1258; doi:10.2337/diabetes.45.9.1253

  3. Jensen-Urstad, M T

    • Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes September 1996 45:1253-1258; doi:10.2337/diabetes.45.9.1253

K

  1. Kamal, A

    • Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes September 1996 45:1259-1266; doi:10.2337/diabetes.45.9.1259

  2. Kanegae, Y

    • Effect of mitochondrial and/or cytosolic glycerol 3-phosphate dehydrogenase overexpression on glucose-stimulated insulin secretion from MIN6 and HIT cells. Diabetes September 1996 45:1238-1244; doi:10.2337/diabetes.45.9.1238

  3. Katagiri, H

    • Effect of mitochondrial and/or cytosolic glycerol 3-phosphate dehydrogenase overexpression on glucose-stimulated insulin secretion from MIN6 and HIT cells. Diabetes September 1996 45:1238-1244; doi:10.2337/diabetes.45.9.1238

  4. Kern, T S

    • Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants. Diabetes September 1996 45:1233-1237; doi:10.2337/diabetes.45.9.1233

  5. Kikuchi, M

    • Effect of mitochondrial and/or cytosolic glycerol 3-phosphate dehydrogenase overexpression on glucose-stimulated insulin secretion from MIN6 and HIT cells. Diabetes September 1996 45:1238-1244; doi:10.2337/diabetes.45.9.1238

  6. Knowler, W C

    • Absence of linkage of obesity and energy metabolism to markers flanking homologues of rodent obesity genes in Pima Indians. Diabetes September 1996 45:1229-1232; doi:10.2337/diabetes.45.9.1229

  7. Kowluru, R A

    • Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants. Diabetes September 1996 45:1233-1237; doi:10.2337/diabetes.45.9.1233

  8. Kumagaye, K Y

    • Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes September 1996 45:1279-1281; doi:10.2337/diabetes.45.9.1279

L

  1. Leibel, R L

    • Absence of linkage of obesity and energy metabolism to markers flanking homologues of rodent obesity genes in Pima Indians. Diabetes September 1996 45:1229-1232; doi:10.2337/diabetes.45.9.1229

  2. Lenti, L

    • Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes. Diabetes September 1996 45:1193-1196; doi:10.2337/diabetes.45.9.1193

  3. Leslie, R D

    • Concordance between twins for beta-cell autoimmunity. Diabetes September 1996 45:1284

  4. Lindblad, L E

    • Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes September 1996 45:1253-1258; doi:10.2337/diabetes.45.9.1253

  5. Lucidi, P

    • Contribution of amino acids and insulin to protein anabolism during meal absorption. Diabetes September 1996 45:1245-1252; doi:10.2337/diabetes.45.9.1245

M

  1. Madsbad, S

    • Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover. Diabetes September 1996 45:1267-1275; doi:10.2337/diabetes.45.9.1267

  2. Majno, G

    • Anti-endothelial cell autoantibodies in BB rats with spontaneous and induced IDDM. Diabetes September 1996 45:1209-1216; doi:10.2337/diabetes.45.9.1209

  3. Mally, M I

    • Regulation of proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, hepatocyte growth factor, and cell-cell contact. Diabetes September 1996 45:1223-1228; doi:10.2337/diabetes.45.9.1223

  4. Marco, J

    • Effect of enterostatin on insulin, glucagon, and somatostatin secretion in the perfused rat pancreas. Diabetes September 1996 45:1157-1160; doi:10.2337/diabetes.45.9.1157

  5. Maxwell, A P

    • A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes September 1996 45:1204-1208; doi:10.2337/diabetes.45.9.1204

  6. Miyazaki, J

    • Effect of mitochondrial and/or cytosolic glycerol 3-phosphate dehydrogenase overexpression on glucose-stimulated insulin secretion from MIN6 and HIT cells. Diabetes September 1996 45:1238-1244; doi:10.2337/diabetes.45.9.1238

  7. Monacchia, F

    • Contribution of amino acids and insulin to protein anabolism during meal absorption. Diabetes September 1996 45:1245-1252; doi:10.2337/diabetes.45.9.1245

  8. Mordes, J P

    • Anti-endothelial cell autoantibodies in BB rats with spontaneous and induced IDDM. Diabetes September 1996 45:1209-1216; doi:10.2337/diabetes.45.9.1209

N

  1. Nakajima, K

    • Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes September 1996 45:1279-1281; doi:10.2337/diabetes.45.9.1279

  2. Nakazaki, M

    • Effect of mitochondrial and/or cytosolic glycerol 3-phosphate dehydrogenase overexpression on glucose-stimulated insulin secretion from MIN6 and HIT cells. Diabetes September 1996 45:1238-1244; doi:10.2337/diabetes.45.9.1238

  3. Nanjo, K

    • Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes September 1996 45:1279-1281; doi:10.2337/diabetes.45.9.1279

  4. Nevin, N C

    • A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes September 1996 45:1204-1208; doi:10.2337/diabetes.45.9.1204

  5. Nolan, J J

    • Effect of troglitazone on leptin production. Studies in vitro and in human subjects. Diabetes September 1996 45:1276-1278; doi:10.2337/diabetes.45.9.1276

  6. Norman, R A

    • Absence of linkage of obesity and energy metabolism to markers flanking homologues of rodent obesity genes in Pima Indians. Diabetes September 1996 45:1229-1232; doi:10.2337/diabetes.45.9.1229

  7. Nyce, M R

    • Effect of troglitazone on leptin production. Studies in vitro and in human subjects. Diabetes September 1996 45:1276-1278; doi:10.2337/diabetes.45.9.1276

O

  1. Ohagi, S

    • Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes September 1996 45:1279-1281; doi:10.2337/diabetes.45.9.1279

  2. Oka, Y

    • Effect of mitochondrial and/or cytosolic glycerol 3-phosphate dehydrogenase overexpression on glucose-stimulated insulin secretion from MIN6 and HIT cells. Diabetes September 1996 45:1238-1244; doi:10.2337/diabetes.45.9.1238

  3. Olefsky, J M

    • Effect of troglitazone on leptin production. Studies in vitro and in human subjects. Diabetes September 1996 45:1276-1278; doi:10.2337/diabetes.45.9.1276

  4. Orgiazzi, J

    • Lymphocyte function associated antigen-1, integrin alpha 4, and L-selectin mediate T-cell homing to the pancreas in the model of adoptive transfer of diabetes in NOD mice. Diabetes September 1996 45:1181-1186; doi:10.2337/diabetes.45.9.1181

  5. Otonkoski, T

    • Regulation of proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, hepatocyte growth factor, and cell-cell contact. Diabetes September 1996 45:1223-1228; doi:10.2337/diabetes.45.9.1223

P

  1. Pedersen, O

    • Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover. Diabetes September 1996 45:1267-1275; doi:10.2337/diabetes.45.9.1267

  2. Power-Kehoe, L

    • Absence of linkage of obesity and energy metabolism to markers flanking homologues of rodent obesity genes in Pima Indians. Diabetes September 1996 45:1229-1232; doi:10.2337/diabetes.45.9.1229

  3. Previti, M

    • Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes. Diabetes September 1996 45:1193-1196; doi:10.2337/diabetes.45.9.1193

  4. Pyke, D A

    • Concordance between twins for beta-cell autoimmunity. Diabetes September 1996 45:1284

R

  1. Ramakers, G M

    • Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes September 1996 45:1259-1266; doi:10.2337/diabetes.45.9.1259

  2. Ravussin, E

    • Absence of linkage of obesity and energy metabolism to markers flanking homologues of rodent obesity genes in Pima Indians. Diabetes September 1996 45:1229-1232; doi:10.2337/diabetes.45.9.1229

  3. Reboldi, G

    • Contribution of amino acids and insulin to protein anabolism during meal absorption. Diabetes September 1996 45:1245-1252; doi:10.2337/diabetes.45.9.1245

  4. Reichard, P G

    • Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes September 1996 45:1253-1258; doi:10.2337/diabetes.45.9.1253

  5. Rodríguez-Gallardo, J

    • Effect of enterostatin on insulin, glucagon, and somatostatin secretion in the perfused rat pancreas. Diabetes September 1996 45:1157-1160; doi:10.2337/diabetes.45.9.1157

  6. Roep, B O

    • T-cell responses to autoantigens in IDDM. The search for the Holy Grail. Diabetes September 1996 45:1147-1156; doi:10.2337/diabetes.45.9.1147

  7. Rosfors, J S

    • Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes September 1996 45:1253-1258; doi:10.2337/diabetes.45.9.1253

  8. Rubin, J S

    • Regulation of proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, hepatocyte growth factor, and cell-cell contact. Diabetes September 1996 45:1223-1228; doi:10.2337/diabetes.45.9.1223

S

  1. Saito, I

    • Effect of mitochondrial and/or cytosolic glycerol 3-phosphate dehydrogenase overexpression on glucose-stimulated insulin secretion from MIN6 and HIT cells. Diabetes September 1996 45:1238-1244; doi:10.2337/diabetes.45.9.1238

  2. Sakagashira, S

    • Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes September 1996 45:1279-1281; doi:10.2337/diabetes.45.9.1279

  3. Saldeen, J

    • Efficient gene transfer to dispersed human pancreatic islet cells in vitro using adenovirus-polylysine/DNA complexes or polycationic liposomes. Diabetes September 1996 45:1197-1203; doi:10.2337/diabetes.45.9.1197

  4. Salmi, M

    • Mucosa-associated (beta 7-integrinhigh) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior. Diabetes September 1996 45:1173-1180; doi:10.2337/diabetes.45.9.1173

  5. Sanke, T

    • Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes September 1996 45:1279-1281; doi:10.2337/diabetes.45.9.1279

  6. Scaglia, L

    • Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes September 1996 45:1161-1167; doi:10.2337/diabetes.45.9.1161

  7. Shimomura, H

    • Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes September 1996 45:1279-1281; doi:10.2337/diabetes.45.9.1279

  8. Silvestre, R A

    • Effect of enterostatin on insulin, glucagon, and somatostatin secretion in the perfused rat pancreas. Diabetes September 1996 45:1157-1160; doi:10.2337/diabetes.45.9.1157

  9. Simell, O

    • Mucosa-associated (beta 7-integrinhigh) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior. Diabetes September 1996 45:1173-1180; doi:10.2337/diabetes.45.9.1173

  10. Spruijt, B M

    • Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes September 1996 45:1259-1266; doi:10.2337/diabetes.45.9.1259

  11. Strandell, E

    • Efficient gene transfer to dispersed human pancreatic islet cells in vitro using adenovirus-polylysine/DNA complexes or polycationic liposomes. Diabetes September 1996 45:1197-1203; doi:10.2337/diabetes.45.9.1197

T

  1. Thivolet, C

    • Lymphocyte function associated antigen-1, integrin alpha 4, and L-selectin mediate T-cell homing to the pancreas in the model of adoptive transfer of diabetes in NOD mice. Diabetes September 1996 45:1181-1186; doi:10.2337/diabetes.45.9.1181

  2. Thompson, D B

    • Absence of linkage of obesity and energy metabolism to markers flanking homologues of rodent obesity genes in Pima Indians. Diabetes September 1996 45:1229-1232; doi:10.2337/diabetes.45.9.1229

  3. Tibell, A

    • Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover. Diabetes September 1996 45:1267-1275; doi:10.2337/diabetes.45.9.1267

U

  1. Urban, I J

    • Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes September 1996 45:1259-1266; doi:10.2337/diabetes.45.9.1259

V

  1. Vestergaard, H

    • Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover. Diabetes September 1996 45:1267-1275; doi:10.2337/diabetes.45.9.1267

  2. Volpi, E

    • Contribution of amino acids and insulin to protein anabolism during meal absorption. Diabetes September 1996 45:1245-1252; doi:10.2337/diabetes.45.9.1245

W

  1. Wanke, I E

    • Phlorizin or vanadate treatment reverses impaired expression of albumin and hepatocyte nuclear factor 1 in diabetic rats. Diabetes September 1996 45:1217-1222; doi:10.2337/diabetes.45.9.1217

  2. Wasmeier, C

    • Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes September 1996 45:1187-1192; doi:10.2337/diabetes.45.9.1187

  3. Weir, G C

    • Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes September 1996 45:1161-1167; doi:10.2337/diabetes.45.9.1161

  4. Welsh, N

    • Efficient gene transfer to dispersed human pancreatic islet cells in vitro using adenovirus-polylysine/DNA complexes or polycationic liposomes. Diabetes September 1996 45:1197-1203; doi:10.2337/diabetes.45.9.1197

  5. Wong, N C

    • Phlorizin or vanadate treatment reverses impaired expression of albumin and hepatocyte nuclear factor 1 in diabetic rats. Diabetes September 1996 45:1217-1222; doi:10.2337/diabetes.45.9.1217

Y

  1. Yazaki, Y

    • Effect of mitochondrial and/or cytosolic glycerol 3-phosphate dehydrogenase overexpression on glucose-stimulated insulin secretion from MIN6 and HIT cells. Diabetes September 1996 45:1238-1244; doi:10.2337/diabetes.45.9.1238

Z

  1. Zangen, D H

    • Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes September 1996 45:1161-1167; doi:10.2337/diabetes.45.9.1161

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement